The COVID-19 Pandemic – News and Features

Researchers from Children’s Hospital of Philadelphia report important data that differentiate MIS-C from severe COVID-19 in children and suggest that MIS-C is a post-infectious syndrome related to COVID-19 but distinct from KD.

Technology Networks recently spoke with Bryan Witherbee, CEO, Ardaza, to learn more about ZIVA, a multiplex label-free biosensor platform, and discuss some of the applications it could benefit.

To learn more about plasma viscosity and how it can be measured, as well as understand how this information could potentially be used to help diagnose and treat COVID-19 patients, Technology Networks spoke with Bernie Benson, MD of Benson Viscometers.

Researchers from Vanderbilt University have developed a streamlined diagnostic approach for COVID-19 that renders RNA extraction – a bottleneck in the diagnostic process – unnecessary.

A Swiss-German team has developed a test that determines the amount of SARS-CoV-2 neutralizing antibodies within a short period of time.

Trials for specially-trained "COVID dogs" that may be able to detect coronavirus in humans, even before symptoms appear, are now underway.

Researchers have identified several characteristics of SAR-CoV-2’s Nsp16 and Nsp10 protein complex. These characteristics may be targeted by inhibitors that suppress the activity of the Nsp16 and Nsp10 protein complex, aiding the design of drugs against the virus.

Researchers are conducting a Phase 2 clinical trial to determine if the oral cancer drug ibrutinib can help patients with cancer or other immunocompromised conditions recover from COVID-19.

Scientists have taken a deeper look at how the immune system changes with age and their findings could help to make flu vaccines much more protective.

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.